Skip to main content
. 2017 Jan 5;116(3):356–361. doi: 10.1038/bjc.2016.427

Table 1. Patients characteristics (N=141).

  No. of patients Percent
Age (years)
Median 56.6  
Range (30–84)  
PS
<2 119 84%
⩾2 23 16%
Receptor status
ER positive 102 72%
ER negative 39 27%
Her2/neu
Positive 26 19%
Negative 115 81%
Liver metastasis
Yes 54 36%
No 96 64%
Bone metastasis
Yes 56 40%
No 85 60%
Number of metastatic sites
⩽4 124 88%
>4 17 12%
Lactate dehydrogenase
⩽600 109 78%
>600 31 22%